Menu

Nike

NYSE: NKE

Nike, Inc. (NKE) is a global sportswear company that designs, markets, and sells athletic footwear, apparel, equipment, and accessories. Its major brands include Nike, Jordan, and Converse. The company sells products through its own retail stores, digital platforms, and wholesale partners worldwide. Investors closely monitor revenue growth, consumer demand, profit margins, inventory levels, and competition in the global sportswear market.

Sector
Consumer Non-Durables
Industry
Apparel/Footwear
Employees
73,000
Founded
1964

The forecast figures are tipranks’s, read on 2026-10-25 and linked below.
The company facts and financials are CNN Business’s, read on 2026-11-05 and linked below.

Nike forecast

The forecast in short

tipranks records 36 analyst ratings on Nike and summarises them as “Hold”. Their average 12-month price target is USD 36.58 (Potential Growth = -1.92%). Its tipranks score is 1 out of 10 — Underperform. These are tipranks’s figures as read on 2026-10-25, not CariBroker’s own view, and nothing here is advice to buy or sell.

Market cap

USD 53.93 B

≈ RM 220.61 B

Share price

USD 36.31

≈ RM 148.53 · 18 Nov close

#441World ranking

tipranks score

Underperform

1

Analyst ratings

Hold

  • Buy925%
  • Hold1850%
  • Sell925%

tipranks’s own summary of the 36 ratings above.

12 months price forecast

USD 36.58 Potential Growth = -1.92%

USD 14.64USD 32.07USD 49.5USD 66.93Past 12 months12 months forecastHighUSD 62AverageUSD 36.58LowUSD 192025-102026-10

As tipranks publishes it. CariBroker has not recalculated any of it.

Financials

Q1 earnings, quarter ending Aug 30, 2026

MeasureQ1 20261-year change
Total revenue11.22B0.52% down
Net income712.00M36.92% up
Earnings per share0.482.42% down
Net profit margin6.35%2.39% up
Free cash flow-64.00M122.54% down
Debt-to-equity ratio0.7311.42% down

Revenue and net income, last 4 quarters

$0.0$2.5B$5.0B$7.5B$10.0B$12.5BQ2 2025Q3 2025Q4 2025Q1 2026

Total revenueNet income

Analyst profiles: who made each call, and when

AnalystFromPositionTarget priceDated
Anna AndreevaPiper SandlerHoldUSD 282026-10-22
Ashley OwensKeyBancHoldN/A2026-10-22
Aneesha ShermanBernsteinBuyUSD 452026-10-22
Matthew BossJ.P. MorganSellUSD 332026-10-22
Adrienne YihBarclaysBuyUSD 452026-10-22
Show all 36
AnalystFromPositionTarget priceDated
Spencer HanusWolfe ResearchSellUSD 282026-10-21
Lorraine HutchinsonBank of America SecuritiesSellUSD 242026-10-21
Robert DrbulBTIGBuyUSD 502026-10-21
Christine DooleyArgus ResearchBuyUSD 422026-10-16
Nick Anderson CFABerenberg BankSellUSD 27.52026-10-14
Jay SoleUBSHoldN/A2026-10-13
Krisztina KataiDeutsche BankHoldUSD 332026-10-09
Cristina FernandezTelsey AdvisoryHoldUSD 352026-10-06
Peter McGoldrickStifel NicolausHoldUSD 362026-10-05
Paul LejuezCitiHoldUSD 322026-10-05
Piral DadhaniaRBC CapitalHoldUSD 402026-10-02
Joseph CivelloTruist FinancialHoldUSD 292026-10-02
Katharina SchmengerDZ BANK AGSellN/A2026-10-02
Ike BoruchowWells FargoHoldUSD 302026-10-02
Georgy VashchenkoFreedom Capital MarketsBuyUSD 512026-10-02
Randal KonikJefferiesBuyUSD 602026-10-02
Kelly CragoBMO CapitalSellUSD 252026-10-02
Laurent VasilescuExane BNP ParibasSellUSD 192026-10-02
Zachary WarringCFRABuyUSD 622026-10-02
Alexandra StratonMorgan StanleySellUSD 272026-10-02
Tom NikicNeedhamHoldN/A2026-10-02
Michael BinettiEvercore ISIHoldUSD 282026-10-02
Jonathan KompRobert W. BairdHoldUSD 362026-10-02
Sam PoserWilliams TradingHoldUSD 302026-10-02
Brooke RoachGoldman SachsHoldUSD 302026-10-01
Simeon SiegelGuggenheimBuyUSD 502026-10-01
Rick PatelRaymond JamesHoldN/A2026-09-29
Akshay GuptaHSBCHoldUSD 402026-09-28
Brian NagelOppenheimerBuyUSD 522026-09-28
Unknown AnalystBank of ChinaSellUSD 302026-09-25
Alison FokDBSBuyUSD 712026-03-04

Investment strengths

Performance portfolio growth

Broad-based growth across multiple sports demonstrates that Nike still has product innovation, brand relevance, and category depth beyond its challenged lifestyle franchises. Continued gains in Performance can diversify revenue, strengthen consumer engagement, and provide a durable foundation for recovery.

Gross margin and expense discipline

Improving gross margin alongside lower reported SG&A shows that management retains meaningful control over costs despite weaker demand. This discipline can help protect profitability during the transition and preserve resources for product innovation, marketing, and marketplace investments.

Strong balance sheet

A net-cash position and substantial liquidity give Nike flexibility to fund restructuring, sustain strategic investment, and continue shareholder distributions while operating trends recover. This financial resilience reduces dependence on external financing and supports long-term brand and channel initiatives.

People also ask

What is the 12-month price target for Nike (NKE)?

tipranks publishes an average 12-month price target of USD 36.58 (Potential Growth = -1.92%), as read on 2026-10-25. The highest target is USD 62 and the lowest is USD 19. A price target is an analyst’s estimate of where a share might trade, not a promise, and CariBroker gives no investment advice.

See tipranks’s own page ↗

How many analysts cover Nike (NKE)?

tipranks records 36 analyst ratings: 9 buy, 18 hold and 9 sell, which it summarises as “Hold”, as read on 2026-10-25.

See tipranks’s own page ↗

What is the tipranks score for Nike (NKE)?

tipranks scores it 1 out of 10 and calls that “Underperform”, as read on 2026-10-25. The score is tipranks’s, not CariBroker’s, and CariBroker does not rate listed shares.

See tipranks’s own page ↗

Is this CariBroker’s own forecast for Nike?

No. Every figure on this page is published by tipranks, copied on 2026-10-25 with a link to the original, and not recalculated. CariBroker checks financial companies in Malaysia against the public registers; it makes no forecast of its own and holds no licence to advise on securities.

See tipranks’s own page ↗

Disclaimer

CariBroker provides information only and does not provide investment, financial or legal advice.

All investment ideas

Check another company

Search every bank, broker and alert list in one place